Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Improving diagnosis and linkage to care for patients infected with Hepatitis C in the prenatal population of Alberta
EF 2019-20
Résumé
"Hepatitis C (HCV) is a detrimental virus that can be transmitted through blood contact or from mother to infant during pregnancy. Currently in Alberta, the prenatal screening panel does not include HCV. However, with the increase in the opioid crisis in the last decade, the prevalence of HCV in women of childbearing age has increased drastically, leading the province of Alberta to consider implementing universal HCV screening in their prenatal panels. In order to do so, universal screening would have to be considered beneficial for prenatal patients and their infants. Our research focuses on determining the current prevalence and epidemiology of HCV in the prenatal population of Alberta through a universal pilot screening project. HCV antibody testing will be added to prenatal screening panels throughout Alberta for the duration of the next two years. Results from all screening tests will be available through ProvLab's Laboratory Information System online. Data will be analyzed monthly using STATA biostatistical software to determine the prevalence and cost-effectiveness compared to the current risk-based screening. If universal screening is overall more beneficial for patients, a recommendation will be made to Alberta Health to implement this strategy in prenatal panels. Moreover, we propose to generate a new referral system, where women and their infants testing positive for HCV will be directly referred to a specialized physician in their corresponding area. We aim to refer 100% of infected women and their infants to physicians for treatment. Effectiveness of direct linkage to care will be assessed by analyzing diagnostic times to patient outcomes. Overall, we expect this will increase the quality of patient care for women and infants infected with HCV in Alberta. "
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
429117
Name
Thompson Leigh-Ann A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving diagnosis and linkage to care for patients infected with Hepatitis C in the prenatal population of Alberta
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alberta; Diagnosis; Epidemiology; Health Policy; Hepatitis C; Linkage To Care; Prenatal; Public Health; Referral; Universal Screening
Abstract
"Hepatitis C (HCV) is a detrimental virus that can be transmitted through blood contact or from mother to infant during pregnancy. Currently in Alberta, the prenatal screening panel does not include HCV. However, with the increase in the opioid crisis in the last decade, the prevalence of HCV in women of childbearing age has increased drastically, leading the province of Alberta to consider implementing universal HCV screening in their prenatal panels. In order to do so, universal screening would have to be considered beneficial for prenatal patients and their infants. Our research focuses on determining the current prevalence and epidemiology of HCV in the prenatal population of Alberta through a universal pilot screening project. HCV antibody testing will be added to prenatal screening panels throughout Alberta for the duration of the next two years. Results from all screening tests will be available through ProvLab's Laboratory Information System online. Data will be analyzed monthly using STATA biostatistical software to determine the prevalence and cost-effectiveness compared to the current risk-based screening. If universal screening is overall more beneficial for patients, a recommendation will be made to Alberta Health to implement this strategy in prenatal panels. Moreover, we propose to generate a new referral system, where women and their infants testing positive for HCV will be directly referred to a specialized physician in their corresponding area. We aim to refer 100% of infected women and their infants to physicians for treatment. Effectiveness of direct linkage to care will be assessed by analyzing diagnostic times to patient outcomes. Overall, we expect this will increase the quality of patient care for women and infants infected with HCV in Alberta. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Thompson, Leigh-Ann A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~